Molecular Partners | BiotechTV

top of page

Search

Swiss Biotech Day: Molecular Partners' CEO and Swiss Biotech Association president Patrick Amstutz shares his take on biotech and previews what to expect from his U.S. listed company in 2025

Swiss Biotech Day: Molecular Partners' CEO and Swiss Biotech Association president Patrick Amstutz shares his take on biotech and previews what to expect from his U.S. listed company in 2025

Swiss Biotech Day: Molecular Partners' CEO and Swiss Biotech Association president Patrick Amstutz shares his take on biotech and previews what to expect from his U.S. listed company in 2025

He describes the clinical multi-specific T-cell engager program that will have data this year, and highlights the idea behind a...

12 hours ago

The Co-Founder & CEO of Zurich based Molecular Partners describes their DARPin technology platform and how it is being put to use

The Co-Founder & CEO of Zurich based Molecular Partners describes their DARPin technology platform and how it is being put to use

The Co-Founder & CEO of Zurich based Molecular Partners describes their DARPin technology platform and how it is being put to use

Patrick Amstutz discusses the properties of DARPins that make them ideal building blocks of multispecifics and use cases such as immuno...

Sep 23, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page